Immunotherapy has transformed the management of lung cancer. This book provides an in-depth analysis of the mechanisms of action predictive biomarkers and optimization strategies of immunotherapies. It addresses clinical challenges side-effect management and future prospects including combination therapies and new targets. An indispensable resource for oncologists pulmonologists researchers and all professionals involved in the fight against lung cancer.